about
Pathophysiological Function of ADAMTS Enzymes on Molecular Mechanism of Alzheimer's DiseaseVon Willebrand disease: an overviewWhat a polyclonal antibody sees in von Willebrand factor.Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura.The combined roles of ADAMTS13 and VWF in murine models of TTP, endotoxemia, and thrombosis.Thrombotic thrombocytopenic purpura and multiorgan system failure in a child with sickle cell-hemoglobin C disease.ADAMTS13 gene mutations in children with hemolytic uremic syndrome.ADAMTS13 activity and antigen during therapy and follow-up of patients with idiopathic thrombotic thrombocytopenic purpura: correlation with clinical outcomeHemolysis and hemolytic uremic syndrome following five-fold N-acetylcysteine overdose.Endothelial cells and thrombotic microangiopathy.Diagnostic and prognostic values of ADAMTS13 activity measured during daily plasma exchange therapy in patients with acquired thrombotic thrombocytopenic purpura.Effects of increased von Willebrand factor levels on primary hemostasis in thrombocytopenic patients with liver cirrhosisSevere Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibitionThe management of immune thrombocytopenic purpura.Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis.Characterization of conformation-sensitive antibodies to ADAMTS13, the von Willebrand cleavage proteaseLocalization of blood proteins thrombospondin1 and ADAMTS13 to cerebral corpora amylacea.Successful peripheral blood stem cell mobilization using pegfilgrastim in allogeneic stem cell transplantation.Detection of a secreted metalloprotease within the nuclei of liver cellsThrombotic microangiopathy in haematopoietic cell transplantation: an update.Hypochlorous acid generated by neutrophils inactivates ADAMTS13: an oxidative mechanism for regulating ADAMTS13 proteolytic activity during inflammation.Probing ADAMTS13 substrate specificity using phage displayEvaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis.Critical care perspective on immunotherapy in lung transplantation.How do you treat bleeding disorders with desmopressin?von Willebrand factor: at the crossroads of bleeding and thrombosis.Evaluation of morpho/immunological telehaematology file exchanges for the inclusion of patients with chronic lymphocytic leukaemia in a therapeutic trial.Proposal of a genetic classifier for risk group stratification in pediatric T-cell lymphoblastic lymphoma reveals differences from adult T-cell lymphoblastic leukemia.Expression of ADAMTS-2, -3, -13, and -14 in culprit coronary lesions in patients with acute myocardial infarction or stable angina.Thrombus Formation and Propagation in the Onset of Cardiovascular Events
P2860
Q26738884-B11D1733-B00F-404A-9139-0AFEA5B305A6Q28742241-CDE1C84D-61C2-4FA5-81A4-B518AE775049Q33290062-6B55EA72-791A-42B7-881D-A8E21F2CDF33Q33371690-E5B9D302-FB45-46E0-976E-C017A2B0E8B2Q33377815-CEF255E6-85C5-4BC1-8011-731F2EF6AA98Q33385001-985CCD61-D49E-43E6-88CE-22B960598C2EQ33394897-27A821C0-560B-48E1-A054-55A64E270163Q33395460-97B5EAE1-8025-4C13-9035-6BB4AD25587FQ33397473-C0AEC35B-4A2F-439F-93F3-F585CE87EC42Q33401369-78EA3190-6F02-4F29-83B0-B4EC5F6E9F6CQ33416047-E74E6938-C3E2-4F57-9D8D-1B820968A38AQ33418710-4DB668A9-7CD5-46BD-BEFD-A8A5253AE0B4Q33419829-5002C155-65D8-4A6B-8DA3-BCEBC6552A03Q33428804-6C02F0F7-AA34-41EC-AA1C-384004CB4C71Q33440172-CD3B70D1-F2A4-4C64-B093-E2809B154808Q33490606-40D3DCAB-3432-4420-A7DE-CCBEBE794137Q33857205-A2684C6C-2A76-41A5-B495-B7D8B8E69A16Q34659309-0BA699D2-1518-4C7F-8B0D-50B5C61B92FAQ35083378-6A04AB7A-A56F-4B28-A9DB-4ED912A01139Q35098992-E6077DA0-F510-4623-8790-15DB9E89B992Q35121231-46B622FB-BDA6-41DF-9973-2ABEEBDC047BQ35596768-1FD42302-CFF3-4447-94ED-7BCCE72FF912Q35836009-DEA83C04-5975-422A-9A23-4D10B50585C8Q36649380-2EC40C9F-66C8-47BA-A7D8-C665672B4E6EQ36754092-BFACE862-03E4-488D-803F-2215F34AAE9EQ38000162-7E111E95-F0F7-44FB-A8B9-9E206B2E1456Q46596458-E134727C-BB83-49D6-9435-B78C1FFD27DAQ48153742-65CCCC1C-734D-492E-B00D-259C80B30C45Q53393282-7E381173-36A0-4F69-A466-4D5F0755B379Q58805706-4A95FD25-0727-4E00-A372-F407B92C0A59
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
ADAMTS13 turns 3
@ast
ADAMTS13 turns 3
@en
ADAMTS13 turns 3
@nl
type
label
ADAMTS13 turns 3
@ast
ADAMTS13 turns 3
@en
ADAMTS13 turns 3
@nl
prefLabel
ADAMTS13 turns 3
@ast
ADAMTS13 turns 3
@en
ADAMTS13 turns 3
@nl
P2093
P1433
P1476
ADAMTS13 turns 3
@en
P2093
David G Motto
David Ginsburg
Gallia G Levy
P356
10.1182/BLOOD-2004-10-4097
P407
P577
2005-07-01T00:00:00Z